Stay updated on Nivolumab Post Induction in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Post Induction in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.5.2 to v3.5.3, reflecting a website release without altering the study content.
    Difference
    0.1%
    Check dated 2026-04-24T06:30:39.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:47:00.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0, replacing Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:20:34.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:51:59.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior Revision: v3.4.1 along with the government funding/status notice.
    Difference
    0.5%
    Check dated 2026-02-11T14:09:18.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    A government funding status notice was added indicating possible delays and that the NIH Clinical Center is open, with links to status updates. The site revision was updated to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T10:16:20.000Z thumbnail image

Stay in the know with updates to Nivolumab Post Induction in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.